2021
DOI: 10.1111/1751-2980.13029
|View full text |Cite
|
Sign up to set email alerts
|

Hamartomatous polyposis syndrome associated malignancies: Risk, pathogenesis and endoscopic surveillance

Abstract: Hamartomatous polyposis syndromes (HPS) are a heterogeneous spectrum of diseases that are characterized by diffuse hamartomatous polyps lining the gastrointestinal (GI) tract together with extra‐GI manifestations. Classical HPS includes juvenile polyposis syndrome, Peutz–Jeghers syndrome, PTEN hamartoma tumor syndrome and hereditary mixed polyposis syndrome. Patients with HPS have a higher risk of GI and extra‐GI malignancies than the general population, although the underlying mechanisms remain unclear and ar… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
7
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

3
3

Authors

Journals

citations
Cited by 8 publications
(8 citation statements)
references
References 67 publications
(97 reference statements)
0
7
0
Order By: Relevance
“…By contrast, solitary JPS is frequently less predictive of a malignant tumor tendency ( 8 ). Juvenile polyps of the colorectum are the most common type of polyp in children but are rare in adults ( 9 , 10 ). The present case report provides details on the diagnosis and treatment process of an adult solitary juvenile rectal polyp with elevated fecal calprotectin (FCP).…”
Section: Introductionmentioning
confidence: 99%
“…By contrast, solitary JPS is frequently less predictive of a malignant tumor tendency ( 8 ). Juvenile polyps of the colorectum are the most common type of polyp in children but are rare in adults ( 9 , 10 ). The present case report provides details on the diagnosis and treatment process of an adult solitary juvenile rectal polyp with elevated fecal calprotectin (FCP).…”
Section: Introductionmentioning
confidence: 99%
“…Intermediate‐ to full‐dose corticosteroids is the first choice for the induction of remission in active CCS, whereas a low‐dose corticosteroid (prednisone <10 mg/d) or azathioprine is usually used for the maintenance therapy 4 . Whether diffuse gastrointestinal polyps in CCS possess malignant potential remains controversial 5 . A national survey in Japan showed that CCS patients had an increased lifetime risk of gastrointestinal cancer compared to the general population, with gastric cancer and colonic cancer detected in 9.1% and 19.5% of cases, respectively 2 .…”
Section: Introductionmentioning
confidence: 99%
“…4 Whether diffuse gastrointestinal polyps in CCS possess malignant potential remains controversial. 5 A national survey in Japan showed that CCS patients had an increased lifetime risk of gastrointestinal cancer compared to the general population, with gastric cancer and colonic cancer detected in 9.1% and 19.5% of cases, respectively. 2 Polyps are also accompanied by adenomatous changes occurring in the stomach, duodenum, and colorectum.…”
mentioning
confidence: 99%
“…However, such association needs to be further confirmed. Our previous study showed an improved 5‐year survival rate of CCS, 8 but the unclear pathogenesis and its high malignant potential still hinder further improvement in disease management 9 …”
Section: Introductionmentioning
confidence: 99%
“…Our previous study showed an improved 5-year survival rate of CCS, 8 but the unclear pathogenesis and its high malignant potential still hinder further improvement in disease management. 9 CCS is a syndrome characterized by hamartomatous GI polyps and other extraintestinal manifestations; therefore, it is sometimes categorized as one of the hamartomatous polyposis syndromes (HPS), which include juvenile polyposis syndrome (JPS), Peutz-Jeghers syndrome (PJS), PTEN hamartoma tumor syndrome (PHTS), and other syndromes with multiple hamartomas. 10 The majority of HPS are hereditary syndromes, with a series of HPS-associated genes identified in certain syndromes.…”
mentioning
confidence: 99%